Back to top

OS Dives

OS Therapies, Inc. (NYSE: OSTX) shares began Tuesday sharply lower. The Rockville, Md.-based company, claiming to be the world leader in gene-edited, Listeria-based cancer immunotherapies, today provided ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: